HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leading health and wellness company offering premium probiotic supplements and products containing CBD, has unveiled its new CBD gummy line. Formulated using HempFusion’s proprietary broad-spectrum hemp extract, never an isolate, the new gummies feature natural functional ingredients and premium flavors. The Elderberry CBD Immune Support Gummies include 10 mg of broad-spectrum CBD and 100 mg of elderberry extract, a functional ingredient scientifically studied to support the immune system. HempFusion’s sweet-and-tart Summer Cherry Gummies feature 10 mg of best-in-class broad spectrum CBD in a delicious chew. According to a recent Brightfield Group report, the CBD gummy market is projected to reach $500 million in sales this year, with a forecast of $1.8 billion sales by 2026. In another report, Brightfield reported that immune-boosting benefits were the second most popular health claim that consumers look for when purchasing food, beverage and supplement products. In recent marketing, the gummies have been recommended by two-time Olympic Gold medalist and five-time world champion women bobsled athlete Kaillie Humphries. “Now available from HempFusion.com, our gummy line is our newest revenue driver and is now shipping to major food, drug and mass retail and convenience locations with further distribution planned across international markets as well as ecommerce sites,” said HempFusion Wellness CEO Jason Mitchell, ND, in the press release. “We welcome consumers to learn more and try our delicious new Elderberry CBD Immune Support and Summer Cherry Gummies for themselves by visiting HempFusion.com. Use code Gummyrush25 to enjoy 25% off plus free shipping through Sept. 4, 2021.”
To view the full press release, visit https://cnw.fm/GsUtS
About HempFusion Wellness Inc.
HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research and HF Labs, to approximately 4,000 retailers across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 48 SKUs (“SKUs”) including tinctures, proprietary FDA Drug Listed over-the-counter (“OTC”) topicals, doctor/practitioner lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the US Hemp Roundtable, and HempFusion’s wholly owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex(TM) and are available in stores or online. For more information about the company, visit www.HempFusion.com.
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Do you have questions or are you interested in working with CNW? Ask Our Editor
CBDWire is part of the InvestorBrandNetwork.